Journal of Lung Diseases & Treatment provides the rapid tri-monthly publication of articles in all areas related to Lung Cancer Treatment, Lymphoma, Lung Inflammation and Treatment, Lung Parenchyma, Lung Radiation Therapy, Lung Fibrosis, COPD Treatment, Lung Infection and Treatment. Journal of Lung Diseases & Treatment welcomes the submission of manuscripts that meet the general criteria of significance and scientific excellence. Papers will be published approximately seven working days after acceptance.
The journal also focusing the most advanced research trends in the field of Lung Nodules, Advances in Stage for Lung Cancer Treatment, Lung Adino Carcinoma, Lung Pain Treatment, Lung Development, Cystic Fibrosis, Asthma, Breathing Disorders, Bronchogenic Carcinoma.
As a member of the Publisher International linking Association, PILA, Journal of Lung Diseases & Treatment (of HILARIS SRL) follows the Creative Commons Attribution License and Scholars Open Access publishing policies.
Journal of Lung Diseases and Treatment is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.
Submit manuscript at https://www.scholarscentral.org/submissions/lung-diseases-treatment.html or send as an e-mail attachment to the Editorial Office at [email protected]
A manuscript number will be e-mailed to the corresponding author within 72 hours. Publication Ethics and Malpractice Statement
Note: Authors are solely responsible for any scientific misconduct including plagiarism in their research articles; the publisher is not responsible for any scientific misconduct that happened in any published research article. As a publisher we will follow strictly scientific guidelines and Editor-in-Chief advice to retract or erratum of any article at any time if scientific misconduct or errors happened in any article.
HILARIS SRL Policy Regarding the NIH MandateHILARIS SRL will support authors by posting the published version of articles by NIH grant-holders to PubMed Central immediately after publication.
Editorial Policies and ProcessThe Journal of Lung Diseases and Treatment follows a progressive editorial policy that encourages researchers to submit the original research, reviews, and editorial observations as articles, well supported by tables and graphic representation.
Article Processing Charges (APC):
Journal of Lung Diseases & Treatment organized by HILARIS SRL, a self-supporting organization, and does not receive funding from any institution/government. Hence, the operation of the Journal is solely financed by the handling fees received from authors and some academic/corporate sponsors. The handling fees are required to meet the maintenance of the journal. Being an Open Access Journal, Journal of Lung Diseases & Treatment does not receive payment for subscription, as the articles are freely accessible over the internet. Authors of articles are required to pay a fair handling fee for processing their articles. However, there are no submission charges. Authors are required to make payment only after their manuscript has been accepted for publication.
Average Article prorcessing time (APT) is 50 days
Rapid Publication Service
Hilaris Publishing is offering wide range of opportunities, options and services for the prospective authors to publish their scholarly contributions.
The journal caters to the demands of the fast publication without compromising on the editorial quality including manuscript peer-review. This flexibility is being provided to ensure earliest author credibility to their respective contributions and this will also ensure timely dissemination of research outcomes for efficient integration, effective translation and reduced redundancy.
Authors have the option to choose between the standard open access publication service which takes its own course of time for complete publication process or can opt for rapid publication service wherein the article is published at the earliest date (Includes multiple subject experts commissioning for securing earliest peer-review comments). The authors can avail this flexibility based on the personal preference, funding agency guidelines or Institutional or organizational requirements.
Regardless of the option, all manuscripts undergo thorough peer-review process, editorial assessment and production process.
Fast Editorial Execution and Review Process (FEE-Review Process)
Authors who are willing to publish their articles under this mode can make a pre-payment of $99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).
Manuscripts accepted for publication will be charged regular APC.
Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.
Submission of an Article
ï»¿ To reduce delays, authors should assure that the level, length, and format of a manuscript submission conform to HILARIS SRL’s requirements at the submission and each revision stage. Submitted articles should have a summary/abstract, separate from the main text, of up to 300 words. This summary does not include references, numbers, abbreviations, or measurements unless essential. The summary should provide a basic-level introduction to the field; a brief account of the background and principle of the work; a statement of the main conclusions; and 2-3 sentences that place the main findings into a general context. The text may contain a few short subheadings of no more than 40 characters each.
Translation services to make scientific and health care information globally available, HILARIS SRL has launched Translation Services. As per the interest of the scientific community from non-English speaking territories, we have introduced this new feature to facilitate authors to reach a global audience in many major world languages. HILARIS SRL Translation Services help the scientific community to have easy access to all scientific articles not only in English but also in French, Spanish, German, Chinese, and Japanese.
The scientific translations service grants a global presence to the authors and their research. Our language experts in Spanish, French, German, Chinese, and Japanese translate articles from English to the desired world languages and vice-versa as per the author’s requirement.
As an open-access publisher HILARIS SRL does not get any financial contributions from other organizations. Authors who wish to use our translation services and who are interested in publishing their research in the above-mentioned languages are requested to pay the following charges in addition to the article processing charges.
Formats for HILARIS SRL Contributions: HILARIS SRL accepts the following: original articles, reviews, abstracts, addendums, announcements, article-commentaries, book reviews, rapid communications, letters to the editor, annual meeting abstracts, conference proceedings, calendars, case-reports, corrections, discussions, meeting-reports, news, obituaries, orations, product reviews, hypotheses and analyses.
Cover Letter: All submissions should be accompanied by a 500 words or less cover letter briefly stating the significance of the research, agreement of authors for publication, number of figures and tables, supporting manuscripts, and supplementary information. Also, include current telephone and fax numbers, as well as postal and E-mail address of the corresponding author to maintain communication.
Article Preparation GuidelinesManuscript title: The title should be limited to 25 words or less and should not contain abbreviations. The title should be a brief phrase describing the contents of the paper.
Author Information: Complete names and affiliation of all authors, including contact details of the corresponding author (Telephone, Fax, and E-mail address).
Abstract: The abstract should be informative and completely self-explanatory, briefly present the topic, state the scope of the experiments, indicate significant data, and point out major findings and conclusions. The abstract should summarize the manuscript content in 300 words or less. Standard nomenclature should be used and abbreviations should be avoided. The preferable format should accommodate a description of the study background, methods, results, and conclusion. Following the abstract, a list of keywords (3-10) and abbreviations should be included.
Text:Introduction: The introduction should set the tone of the paper by providing a clear statement of the study, the relevant literature on the study subject and the proposed approach or solution. The introduction should be general enough to attract a reader’s attention from a broad range of scientific disciplines.
Materials and Methods: This section should provide a complete overview of the design of the study. Detailed descriptions of materials or participants, comparisons, interventions, and types of analysis should be mentioned. However, only new procedures should be described in detail; previously published procedures should be cited and important modifications of published procedures should be mentioned briefly. Capitalize trade names and include the manufacturer's name and address. Results: The results section should provide complete details of the experiment that are required to support the conclusion of the study. The results should be written in the past tense when describing findings in the authors'experiments. Previously published findings should be written in the present tense. Results and discussion may be combined or in a separate section. Speculation and detailed interpretation of data should not be included in the results but should be put into the discussion section.
Acknowledgment: This section includes acknowledgment of people, grant details, funds, etc.
Note: If an author fails to submit his/her work as per the above instructions, they are pleased to maintain clear titles namely headings, subheadings.
References: Only published or accepted manuscripts should be included in the reference list. Meetings abstracts, conference talks, or papers that have been submitted but not yet accepted should not be cited. All personal communications should be supported by a letter from the relevant authors.HILARIS SRL uses the numbered citation (citation-sequence) method. References are listed and numbered in the order that they appear in the text. In the text, citations should be indicated by the reference number in brackets. Multiple citations within a single set of brackets should be separated by commas. When there are three or more sequential citations, they should be given as a range. Example: "... now enable biologists to simultaneously monitor the expression of thousands of genes in a single experiment [1,5-7,28]". Make sure the parts of the manuscript are in the correct order for the relevant journal before ordering the citations. Figure captions and tables should be at the end of the manuscript. Authors are requested to provide at least one online link for each reference as following (preferably PubMed). Because all references will be linked electronically as much as possible to the papers they cite, proper formatting of the references is crucial. Please use the following style for the reference list:
Examples: Published Papers:
Note: Please list the first five authors and then add "et al." if there are additional authors.Electronic Journal Articles Entrez Programming Utilities
Tables: These should be used at a minimum and designed as simple as possible. We strongly encourage authors to submit tables as .doc format. Tables are to be typed double-spaced throughout, including headings and footnotes. Each table should be on a separate page, numbered consecutively in Arabic numerals, and supplied with a heading and a legend. Tables should be self-explanatory without reference to the text. Preferably, the details of the methods used in the experiments should be described in the legend instead of in the text. The same data should not be presented in both table and graph form or repeated in the text. Cells can be copied from an Excel spreadsheet and pasted into a word document, but Excel files should not be embedded as objects.
Note: If the submission is in PDF format, the author is requested to retain the same in .doc format to aid in the completion of the process successfully.
Figures: The preferred file formats for photographic images are .doc, TIFF, and JPEG. If you have created images with separate components on different layers, please send us the Photoshop files. All images must be at or above intended display size, with the following image resolutions: Line Art 800 dpi, Combination (Line Art + Halftone) 600 dpi, Halftone 300 dpi. See the Image quality specifications chart for details. Image files also must be cropped as close to the actual image as possible. Use Arabic numerals to designate figures and upper case letters for their parts (Figure 1). Begin each legend with a title and include sufficient description so that the figure is understandable without reading the text of the manuscript. Information given in legends should not be repeated in the text.
Figure legends: These should be typed in numerical order on a separate sheet
Tables and Equations as Graphics: If equations cannot be encoded in MathML, submit them in TIFF or EPS format as discrete files (i.e., a file containing only the data for one equation). Only when tables cannot be encoded as XML/SGML can they be submitted as graphics. If this method is used, the font size in all equations and tables must be consistent and legible throughout all submissions.
NIH Manuscript submission workflow
Journal of Lung Diseases & Treatment provides you with full support for the entire NIH Manuscript Submission process – from submission to deposit. A suite of functionality that automates the collection and deposit of manuscripts tied to NIH funding and to comply with NIHMS requirements mentioned in the workflow is as follows.
Submit your (author) NIH funding information at the time of submission.
Supplementary Information: Discrete items of the Supplementary Information (for example, figures, tables) referred to at an appropriate point in the main text of the paper. Summary diagram/figure included as part of the Supplementary Information (optional). All Supplementary Information is supplied as a single PDF file, where possible. File size within the permitted limits for Supplementary Information. Images should be a maximum size of 640 x 480 pixels (9 x 6.8 inches at 72 pixels per inch).
Proofs and Reprints: Electronic proofs will be sent as an e-mail attachment to the corresponding author as a PDF file. Page proofs are considered to be the final version of the manuscript. Except for typographical or minor clerical errors, no changes will be made in the manuscript at the proof stage. The authors will have free electronic access to the full text (HTML, PDF, and XML) of the article. Authors can freely download the PDF file from which they can print unlimited copies of their articles.
Copyright: Submission of a manuscript implies that the work described has not been published before (except in the form of an abstract or as part of a published lecture, or thesis) and that it is not under consideration for publication elsewhere. All works published by HILARIS SRL are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited.